Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 6/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11203182 | 0.88 | TSHR (0.52) | PPARDTSHRKMT2AMEN1CA12 | |
| SCHEMBL28336971 | 0.85 | TSHR (0.48) | PPARDTSHRKMT2ALMNAALDH1A1 | |
| SCHEMBL15951683 | 0.84 | TSHR (0.44) | PPARDTSHRKMT2AMEN1CA12 | |
| SCHEMBL710885 | 0.83 | PPARD (0.54) | PPARDTSHRALDH1A1 | |
| SCHEMBL27939729 | 0.82 | TSHR (0.46) | PPARDTSHRKMT2AMEN1CA12 | |
| SCHEMBL19513947 | 0.81 | PPARD (0.47) | PPARDTSHRALDH1A1HSD17B10 | |
| SCHEMBL11494792 | 0.81 | CYP3A4 (0.45) | TSHRCA12CA2CA9CA14 | |
| SCHEMBL816663 | 0.80 | TSHR (0.55) | TSHRKMT2AMEN1CA12LMNA | |
| SCHEMBL2994652 | 0.80 | TSHR (0.44) | PPARDTSHRKMT2AMEN1CA12 | |
| SCHEMBL9445916 | 0.79 | PPARD (0.48) | PPARDTSHRKMT2AMEN1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118221849-A | Application of metallocene catalyst composition as catalyst in preparation of poly alpha olefin wax | 亚培烯科技(上海)有限公司 | 2024-06-21 | — | — | CN | claimed |
| US-12159967-B2 | Nonaqueous electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-12-03 | — | — | US | disclosed |
| CN-118221849-A | Application of metallocene catalyst composition as catalyst in preparation of poly alpha olefin wax | 亚培烯科技(上海)有限公司 | 2024-06-21 | — | — | CN | disclosed |
| EP-4318719-A2 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2024-02-07 | — | — | EP | disclosed |
| EP-4030524-B1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEM CORP (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-20230343990-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-10-26 | — | — | US | disclosed |
| US-11784342-B2 | Nonaqueous electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-10-10 | — | — | US | disclosed |
| US-20220384840-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-12-01 | — | — | US | disclosed |
| US-11450880-B2 | Nonaqueous electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-09-20 | — | — | US | disclosed |
| EP-4030524-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2022-07-20 | — | — | EP | disclosed |
| WO-2011019839-A2 | GLYCOPEPTIDE AND LIPOGLYCOPEPTIDE ANTIBIOTICS WITH IMPROVED SOLUBILITY | THE MEDICINES COMPANY (US) | 2011-02-17 | — | — | WO | disclosed |
| US-20090281205-A1 | Flame-retardant flexible polyurethane foam | ICL-IP AMERICA INC. | 2009-11-12 | — | — | US | disclosed |
| US-7612213-B2 | (E)-ethyl 7-hydroxy-2-methyl-2-heptenate; (3E, 5E)-tert-butyl-9-(tert-butyldimethylsiloxy)-2-[(E)-ethylid ene]-4-methylnona-3,5-dienate | RIKEN (JP) | 2009-11-03 | — | — | US | disclosed |
| US-20080286628-A1 | Particles Comprising Zwitterionic Structural Elements | WACKER CHEMIE AG (DE) | 2008-11-20 | — | — | US | disclosed |
| EP-1940940-A2 | PARTICLES COMPRISING ZWITTERIONIC STRUCTURAL ELEMENTS | Consortium für elektrochemische Industrie GmbH (DE) | 2008-07-09 | — | — | EP | disclosed |
| WO-2007048691-A2 | PARTICLES COMPRISING ZWITTERIONIC STRUCTURAL ELEMENTS | WACKER CHEMIE AG (DE) | 2007-05-03 | — | — | WO | disclosed |
| US-20050209463-A1 | Novel compound having antitumor activity and process for producing the same | RIKEN (JP) | 2005-09-22 | — | — | US | disclosed |
| US-5296505-A | Reacting dithianepropenol with ethynyl-beta-ionol in presence of organomagnesium compound, hydrogenating triple bond, reducing diol with low-valency titanium | L'OREAL (FR) | 1994-03-22 | — | — | US | disclosed |
| US-5296611-A | Propenals substituted with a dithiane ring and processes for the preparation of these propenals | L'OREAL (FR) | 1994-03-22 | — | — | US | disclosed |
| US-4125575-A | Phosphonylated amides | COMPAGNIE FRANCAISE DE PRODUITS INDUSTRIELS (FR) | 1978-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050209463-A1 | Novel compound having antitumor activity and process for producing the same | MCL1, MYC, HCCS | PPARD 4265/4885TSHR 4175/4885KMT2A 3724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.